The landscape of cancer immunotherapies is evolving rapidly. Although peptides or mRNA vaccines encapsulated in lipid nanoparticles are the most popular platform for personalized cancer vaccines (PVCs ...
Lung cancer remains the leading cause of cancer-related mortality worldwide, underscoring the urgent need for improved therapeutic strategies grounded in ...
A Seattle startup company has inked a deal with Eli Lilly to develop AI-powered cancer treatments. The team at Lila Biologics says they're pioneering the translation of AI design proteins for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results